Clinical Trial Update: Efficacy of Dexmedetomidine for Postoperative Analgesia in Infantile Cataract Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluates dexmedetomidine for postoperative analgesia after infantile cataract surgery, focusing on pain and vomiting outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Cataract

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Postoperative Pain, Postoperative Vomiting | Phase 2, Phase 3 | Status: UNKNOWN